Corcept Therapeutics Inc (NASDAQ:CORT) appears in 377 institutional 13F filings for the quarter ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Mar, 2026 | 12,151,276 | 89,064 | 0.74% | $489,817,956.00 |
| INGALLS & SNYDER LLC | 31 Mar, 2026 | 7,608,716 | 413,656 | 5.75% | $306,707.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Mar, 2026 | 5,682,783 | -75,745 | -1.32% | $229,072,983.00 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 31 Mar, 2026 | 4,820,568 | 4,820,568 | 0.00% | $194,317,096.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 4,077,196 | 4,077,196 | 0.00% | $164,351,771.00 |
| Parallel Advisors, LLC | 31 Mar, 2026 | 3,977,404 | 98,263 | 2.53% | $160,329,155.00 |
| State Street Corp | 31 Mar, 2026 | 3,200,946 | 214,890 | 7.20% | $129,030,133.00 |
| FMR LLC | 31 Mar, 2026 | 3,190,192 | 775,552 | 32.12% | $128,596,647.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 2,713,519 | 44,601 | 1.67% | $109,399,340.00 |
| FIRST TRUST ADVISORS LP | 31 Mar, 2026 | 2,173,376 | 1,480,059 | 213.48% | $87,608,786.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Mar, 2026 | 1,553,135 | -67,198 | -4.15% | $62,596,749.00 |
| TANG CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 1,500,000 | 1,343,236 | 856.85% | $60,465,000.00 |
| UBS Group AG | 31 Mar, 2026 | 1,363,668 | 948,817 | 228.71% | $54,969,457.00 |
| D. E. Shaw & Co., Inc. | 31 Mar, 2026 | 1,181,348 | 1,011,681 | 596.27% | $47,620,138.00 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 31 Mar, 2026 | 1,119,959 | 57,858 | 5.45% | $45,145,547.00 |
| Morgan Stanley | 31 Mar, 2026 | 1,018,845 | -573,214 | -36.00% | $41,069,730.00 |
| MPM BioImpact LLC | 31 Mar, 2026 | 985,700 | 985,700 | 0.00% | $39,733,567.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Mar, 2026 | 945,884 | 917,925 | 3,283.11% | $38,128,584.00 |
| Cerity Partners LLC | 31 Mar, 2026 | 731,689 | -23,606 | -3.13% | $29,494,383.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 725,822 | -136,130 | -15.79% | $29,257,885.00 |